Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.520
-0.260 (-6.88%)
At close: Jun 16, 2026, 4:00 PM EDT
3.491
-0.029 (-0.82%)
After-hours: Jun 16, 2026, 6:52 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $250.58 million as of June 16, 2026. Its market cap has increased by 172.07% in one year.
Market Cap
250.58M
Enterprise Value
77.47M
1-Year Change
172.07%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $250.58M, a decrease of -57.35%. That is a compound annual growth rate of -12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 250.58M | 186.66% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 284.61M |
| Nuvectis Pharma | 284.09M |
| Bicycle Therapeutics | 282.74M |
| Cartesian Therapeutics | 279.42M |
| Armata Pharmaceuticals | 278.15M |
| Eledon Pharmaceuticals | 275.97M |
| Niagen Bioscience | 275.35M |
| Elicio Therapeutics | 273.18M |